3 Year Absolute Returns
47.16% ↑
NAV (₹) on 16 Nov 2026
24.37
1 Day NAV Change
-0.08%
Risk Level
Very High Risk
Rating
-
Aditya Birla Sun Life Pharma & Healthcare Fund is a Equity mutual fund categorized under Sector, offered by Aditya Birla Sun Life AMC Limited. Launched on 20 Jun 2019, investors can start with a ... Read more
AUM
₹ 1,087.96 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 76.10% |
| Hospitals & Medical Services | 21.03% |
| Chemicals - Speciality | 1.00% |
| Insurance Distributor | 0.71% |
| Treps/Reverse Repo | 0.68% |
| Chemicals - Organic - Benzene Based | 0.58% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | 8.83% | ₹ 96.08 | Pharmaceuticals |
| Sun Pharmaceutical Industries Ltd. | 8.35% | ₹ 90.81 | Pharmaceuticals |
| Cipla Ltd. | 7.10% | ₹ 77.28 | Pharmaceuticals |
| Apollo Hospitals Enterprise Ltd. | 6.60% | ₹ 71.75 | Hospitals & Medical Services |
| Sai Life Sciences Ltd. | 4.54% | ₹ 49.41 | Pharmaceuticals |
| Aurobindo Pharma Ltd. | 4.50% | ₹ 48.97 | Pharmaceuticals |
| Ajanta Pharma Ltd. | 4.17% | ₹ 45.37 | Pharmaceuticals |
| Dr. Lal Path labs Ltd. | 3.90% | ₹ 42.43 | Hospitals & Medical Services |
| Mankind Pharma Ltd. | 3.56% | ₹ 38.78 | Pharmaceuticals |
| Emcure Pharmaceuticals Ltd. | 3.06% | ₹ 33.27 | Pharmaceuticals |
| Abbott India Ltd. | 3.05% | ₹ 33.15 | Pharmaceuticals |
| Lupin Ltd. | 2.89% | ₹ 31.41 | Pharmaceuticals |
| Gland Pharma Ltd. | 2.86% | ₹ 31.12 | Pharmaceuticals |
| IPCA Laboratories Ltd. | 2.69% | ₹ 29.22 | Pharmaceuticals |
| Fortis Healthcare Ltd. | 2.39% | ₹ 26.04 | Hospitals & Medical Services |
| Divi's Laboratories Ltd. | 2.34% | ₹ 25.43 | Pharmaceuticals |
| Corona Remedies Ltd. | 2.31% | ₹ 25.14 | Pharmaceuticals |
| Dr. Reddy's Laboratories Ltd. | 1.85% | ₹ 20.14 | Pharmaceuticals |
| Procter & Gamble Health Ltd. | 1.83% | ₹ 19.96 | Pharmaceuticals |
| Biocon Ltd. | 1.79% | ₹ 19.42 | Pharmaceuticals |
| Alkem Laboratories Ltd. | 1.65% | ₹ 17.92 | Pharmaceuticals |
| Eris Lifesciences Ltd. | 1.59% | ₹ 17.35 | Pharmaceuticals |
| Jupiter Life Line Hospitals Ltd. | 1.55% | ₹ 16.90 | Hospitals & Medical Services |
| Metropolis Healthcare Ltd. | 1.54% | ₹ 16.73 | Hospitals & Medical Services |
| Piramal Pharma Ltd. | 1.53% | ₹ 16.68 | Pharmaceuticals |
| Thyrocare Technologies Ltd. | 1.49% | ₹ 16.18 | Hospitals & Medical Services |
| Anthem Biosciences Ltd. | 1.08% | ₹ 11.74 | Pharmaceuticals |
| Vijaya Diagnostic Centre Ltd. | 1.04% | ₹ 11.31 | Hospitals & Medical Services |
| Manipal Health Enterprises Ltd | 1.00% | ₹ 10.87 | Hospitals & Medical Services |
| Sanofi Consumer Healthcare India Ltd. | 1.00% | ₹ 10.86 | Chemicals - Speciality |
| Suraksha Diagnostic Ltd. | 0.97% | ₹ 10.59 | Hospitals & Medical Services |
| Natco Pharma Ltd. | 0.95% | ₹ 10.28 | Pharmaceuticals |
| Pfizer Ltd. | 0.95% | ₹ 10.35 | Pharmaceuticals |
| Onesource Specialty Pharma Ltd. | 0.86% | ₹ 9.38 | Pharmaceuticals |
| Medi Assist Healthcare Services Ltd. | 0.71% | ₹ 7.72 | Insurance Distributor |
| Syngene International Ltd. | 0.70% | ₹ 7.61 | Pharmaceuticals |
| TREPS | 0.68% | ₹ 7.35 | Others |
| Vinati Organics Ltd. | 0.58% | ₹ 6.35 | Chemicals - Organic - Benzene Based |
| Max Healthcare Institute Ltd. | 0.55% | ₹ 6.02 | Hospitals & Medical Services |
| Jubilant Pharmova Ltd. | 0.54% | ₹ 5.83 | Pharmaceuticals |
| Glaxosmithkline Pharmaceuticals Ltd. | 0.53% | ₹ 5.71 | Pharmaceuticals |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 12.98% | 10.52% | 7.39% | 13.74% |
| Category returns | 7.37% | 5.10% | 9.83% | 22.69% |
The scheme provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹26.37 | 50.25% | 184.01% | 0.00% | ₹963 | 1.06% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹24.56 | 48.26% | 172.60% | 0.00% | ₹963 | 2.34% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.12 | 18.09% | 129.70% | 0.00% | ₹11,131 | 0.89% |
Very High
|
|
HDFC Pharma and Healthcare Fund - Direct Plan
Sector
Direct
|
₹23.46 | 30.32% | 124.36% | 0.00% | ₹3,666 | 1.03% |
Very High
|
What is the current NAV of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW-Reinvestment?
What is the fund size (AUM) of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW-Reinvestment?
What are the historical returns of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW-Reinvestment?
What is the risk level of Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW-Reinvestment?
What is the minimum investment amount for Aditya Birla Sun Life Pharma & Healthcare Fund Regular IDCW-Reinvestment?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article